High ethics, safety and cost-consciousness are three important factors for the pharmeutical and medico industry. At DHI we advise product developers, researchers, industry, and authorities within pharmaceuticals and medical devices on chemical substances.

We are up to date on current legislation and have contact to authorities in Europe and the USA. We combine our knowledge of legislation with our expertise in risk assessments and in writing toxicological expert reports.

Furthermore, DHI assists in setting up preclinical tests and with evaluation of test results. We are particularly interested in new test methods that can replace experiments on animals.